Concepedia

Esther Revai Lechtich

ER

5

Publications

124

Citations

5

H-Index

2020

Active since

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Harvard Stem Cell Institute

Massachusetts General Hospital

Esther Revai Lechtich is an author at Brigham and Women's Hospital specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2020–2022

5

Publications

5

Simultaneous downregulation of miR-21 and upregulation of miR-7 has anti-tumor efficacy

Deepak Bhere, Nahid Arghiani, Esther Revai Lechtich et al. · Scientific Reports · 2020 · 41 citations · Full text

Poly(beta-amino ester) nanoparticles enable tumor-specific TRAIL secretion and a bystander effect to treat liver cancer

Hannah J. Vaughan, Camila Gadens Zamboni, Nicholas P. Radant et al. · Molecular Therapy — Oncolytics · 2021 · 28 citations · Full text

, , +18

Anti-EGFR VHH-armed death receptor ligand–engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers

Yohei Kitamura, Nobuhiko Kanaya, Susana Moleirinho et al. · Science Advances · 2021 · 21 citations · Full text

RETRACTED ARTICLE: Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells

Deepak Bhere, Sung Hugh Choi, Pim van de Donk et al. · Nature Communications · 2022 · 18 citations · Full text

Tricistronic expression of MOAP-1, Bax and RASSF1A in cancer cells enhances chemo-sensitization that requires BH3L domain of MOAP-1

Yong Hoi Lee, Siew Wai Pang, Esther Revai Lechtich et al. · Journal of Cancer Research and Clinical Oncology · 2020 · 16 citations · Full text

, , +7

Rows per page

1–5 of 5